AWR vs CEPU

AWR exhibits stable financial health with a Piotroski F-Score of 6/9, indicating moderate strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears fairly valued with a current price of $73.16 near the analyst target of $81.00 and intrinsic value estimate of $81.76, despite trading above the conservative Graham Number of $44.06. Solid profitability metrics—such as a 33.96% operating margin and 13.78% ROE—contrast with a bearish technical trend and weak insider sentiment. Revenue and earnings growth remain positive year-over-year, but recent quarterly volatility and limited analyst coverage warrant caution.

CEPU exhibits strong fundamental health with a Piotroski F-Score of 8/9 and an exceptionally low Debt/Equity ratio of 0.19 compared to the sector average of 1.72. The stock is significantly undervalued relative to its Graham Number ($21.56) and sector P/E (8.67 vs 27.01), suggesting a deep value opportunity. While short-term technicals are bearish and earnings surprises have been volatile, the company's high profit margins (31.56%) and robust revenue growth provide a strong safety margin. The discrepancy between the intrinsic value and Graham number suggests a transition from a growth-based valuation to a defensive asset valuation.